P-cadherin expression in breast carcinoma indicates poor survival

Cancer

Volumn 86, Issue 7, 1999, Pages 1263-1272

  Peralta Soler, Alejandro ^a   Knudsen, Karen A ^a   Salazar, Hernando ^b   Han, Aaron C ^b   Keshgegian, Albert A ^c  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b READING HOSPITAL AND MEDICAL CENTER   (United States)

^c LANKENAU HOSPITAL   (United States)

Author keywords

Cadherins and catenins in breast carcinoma; Cap cell carcinoma of the breast; P cadherin; Poor survival

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CADHERIN; CELL ADHESION MOLECULE; ESTROGEN RECEPTOR; NERVE CELL ADHESION MOLECULE; PROGESTERONE RECEPTOR; UVOMORULIN;

ANTIGEN RETRIEVAL; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADULT; ALPHA CATENIN; ANTIBODIES, MONOCLONAL; BETA CATENIN; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; SURVIVAL RATE; TRANS-ACTIVATORS;

EID: 0038387379     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991001)86:7<1263::AID-CNCR23>3.0.CO;2-2     Document Type: Article

References (56)

1. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;51:1451-5.
2. Grunwald GB. The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr Opin Cell Biol 1993;5:797-805.
3. Tsukita S, Tsukita S, Nagafuchi A, Yonemura S. Molecular linkage between cadherins and actin filaments in cell-cell adherens junctions. Curr Opin Cell Biol 1992;4:834-9.
4. Knudsen KA, Wheelock MJ. Plakoglobin, or an 83-kD homologue distinct from β-catenin, interacts with E-cadherin and N-cadherin. J Cell Biol 1992;118:671-9.
5. Knudsen KA, Peralta Soler A, Johnson KR, Wheelock MJ. Interaction of α-actinin with the cadherin/catenin cell-cell adhesion complex via α-catenin. J Cell Biol 1995;130:67-77.
6. Reynolds AB, Daniel J, McCrea PD, Wheelock MJ, Wu J, Zhang Z. Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol Cell Biol 1994;14:8333-42.
7. Wheelock MJ, Knudsen KA. Cadherins and associated proteins. In Vivo 1991;505-13.
8. Vleminckx KL, Vakaet L, Marell MM, Fiers W, van Roy FM. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66:107-19.
9. Behrens J, Vakaet L, Friis R, Winterhager E, van Roy FM, Marcel MM, et al. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 1993;120: 757-66.
10. Hedrick L, Cho KR, Vogelstein B. Cell adhesion molecules as tumour suppressors. Trends Cell Biol 1993;3:36-9.
11. Peifer M. Cancer, catenins, and cuticle pattern: a complex connection. Science 1993;262:1667-8.
12. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993;5:806-11.
13. Rimm DL, Sinard JH, Morrow JS. Reduced α-catenin and E-cadherin expression in breast cancer. Lab Invest 1995;72: 506-12.
14. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993;53:1696-701.
15. Sommers CL, Thompson EW, Torri JA, Kemler R, Gelmann EP, Byers W. Cell adhesion molecule unomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Cell Growth Diff 1991;2:365-72.
16. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 1996;105:394-402.
17. Gamallo C, Palacios J, Suarez A, Pizarro A, Quintanilla M, Cano A. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993;142:987-93.
18. Moll R, Mitze M, Frixen UH, Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993;143:1731-42.
19. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 1993;169: 245-50.
20. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995;55:5195-9.
21. Berx G, Cleton-Jansen A-M, Nollet F, de Leeuw W, van de Vijver M, Cornelisse C, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995;14:6107-15.
22. De Leeuw WJF, Berx G, Vos CBJ, Peterse JL, van de Vijver MJ, Litvinov S, et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997;183:404-11.
23. Hunt NCA, Douglas-Jones AG, Jasani B, Morgan JM, Pignatelli M. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch 1997;430:285-9.
24. Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res 1996;56:4063-70.
25. Leppa S, Vlemincks K, Van Roy F, Jalkanen M. Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent. J Cell Sci 1996;109:1393-403.
26. Lee SW. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nature Med 1996;2:776-82.
27. ctn protein in breast cancer is independent of alpha-and beta-catenin and E-cadherin. Am J Pathol 1998;152:75-82.
28. Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S, et al. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res 1992;52:5770-4.
29. Bukholm, IK, Nesland JM, Karesen R, Jacobsen U, BorresenDale A-L. E-cadherin and α-, β-, and γ-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol 1998;185:262-6.
30. Oyama T, Kanai Y, Ochiai A, Akimoto S, Oda T, Yanagihara K, et al. A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 1994;54:6282-7.
31. Hinck L, Nathke IS, Papkoff J, Nelson WJ. Beta-catenin: a common target for the regulation of cell adhesion by Wnt-1 and Src signaling pathways. Trends Biochem 1994;19:538-42.
32. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988;55:619-25.
33. Palacios J, Benito N, Pizarro A, Suarez A, Espada J, Cano A, et al. Anomalous expression of P-cadherin in breast carcinoma. Am J Pathol 1995;146:605-12.
34. Keshgegian AA. ErB-2 oncoprotein overexpression in breast carcinoma: inverse correlation with biochemically-and immunohistochemically-determined hormone receptors. Breast Cancer Res Treat 1995;35:201-10.
35. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957;11:359-77.
36. Peralta Soler A, Knudsen KA, Jaurand M-C, Johnson KR, Wheelock MJ, Klein-Szanto AJP, et al. The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. Hum Pathol 1995;26:1363-9.
37. Johnson KR, Lewis JE, Li D, Wahl J, Peralta Soler A, Knudsen KA, et al. P- and E- cadherin are in separate complexes in cells expressing both cadherins. Exp Cell Res 1993;207:252-60.
38. Sacco PA, McGranahan TM, Wheelock MJ, Johnson KR. Identification of plakoglobin domains required for association with N-cadherin and α-catenin. J Biol Chem 1995;270: 20201-6.
39. Peralta Soler A, Knudsen KA, Tecson-Miguel A, McBrearty FX, Han AC, Salazar H. The expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. Hum Pathol 1997;28:734-9.
40. Pasha T, Montone KT, Tomaszewski JE. Nuclear antigen retrieval utilizing steam heat. Mod Pathol 1995;8:167.
41. Han AC, Peralta Soler A, Knudsen KA, Wheelock MJ, Johnson KR, Salazar H. Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues. Hum Pathol 1997;28:641-5.
42. Cox DR. Regression models with life-tables. J R Stat Soc 1972;66:188-90.
43. Mehta CR, Patel NR. A network algorithm for performing Fisher's exact test in r × c contingency tables. J Am Stat Soc 1983;78:472-4.
44. Charpin C, Garcia S, Bonnier P, Martini F, Andrac L, Choux R, et al. Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival. Am J Pathol 1998;109:431-8.
45. Daniel CW, Strickland P, Friedmann Y. Expression and functional role of E-and P-cadherins in mouse mammary ductal morphogenesis and growth. Dev Biol 1995;169:511-9.
46. Williams JM, Daniel CW. Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev Biol 1983;97:274-90.
47. Rudland PS. Histochemical organization and cellular composition of ductal buds in developing human breast: evidence of cytochemical intermediates between epithelial and myoepithelial cells. J Histochem Cytochem 1991;39:1471-84.
48. Humphreys RC, Krajewska M, Krnacik S, Jaeger R, Weiher H, Krajewski S, et al. Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of duct morphogenesis. Development 122:4013-22.
49. Snedeker SM, Brown CF, DiAugustine RP. Expression and functional properties of transforming growth factor a and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc Natl Acad Sci USA 1991;88:276-80.
50. Radice GL, Ferreira-Cornwell MC, Robinson SD, Rayburn H, Chodosh LA, Takeichi M, et al. Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol 1997; 139:1025-32.
51. Sapino A, Macri L, Gugliotta P, Pacchioni D, Liu YJ, Medina D, et al. Immunophenotypic properties and estrogen dependency of budding cell structures in the developing mouse mammary gland. Differentiation 1993;55:13-8.
52. Kondapaka SB, Fridman R, Reddy KB. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int J Cancer 1997;70:722-6.
53. Castellani R, Visscher DW, Wykes S, Sarkar FH, Crissman JD. Interaction of transforming growth factor-alpha and epidermal growth factor receptor in breast carcinoma. An immunohistologic study. Cancer 1994;73:344-9.
54. Zarghami N, Grass L, Diamandis EP. Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br J Cancer 1997;75:579-88.
55. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJA, Levesque MA, et al. Prostate specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 1995;55:2104-10.
56. Peralta Soler A, Harner GD, Knudsen KA, McBrearty FX, Grujic E, Salazar H, et al. The expression of P-cadherin identifies PSA negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas: implications for prostate cancer biology. Am J Pathol 1997;151: 471-8.